The Bioclinic Group
The Bioclinic Group is a French medical biology laboratory operator founded in 1995, running a network of patient-facing labs across eight Île-de-France departments and serving individual patients through the INOVIE +ME digital platform and Resulabo secure results portal.
- Company typePrivate
- Founded1995
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2C
- OfferingServices
What The Bioclinic Group does
The Bioclinic Group is a French medical biology laboratory operator founded in 1995, headquartered in Paris, and serving individual patients across eight departments of the Île-de-France region (75, 77, 78, 91, 92, 93, 94, 95). It runs a network of physical laboratory locations offering routine clinical biology testing, including blood tests and diagnostic analyses, with revenue mechanics tied to the French social security / healthcare reimbursement system rather than to publicly disclosed pricing.
Its product portfolio is anchored by INOVIE +ME, a patient-facing web platform launched in 2024 that consolidates access to laboratory services previously distributed across multiple sub-brands (Bioclinic, Guevalt ex-Bioclinic, Sommeville ex-Bioclinic). The platform integrates the Resulabo secure results portal, an FAQ resource, laboratory information and news, and a virtual assistant chatbot for personalized patient inquiries. The architecture is a digital front-end layered on top of the physical lab network, with department-specific login routes preserving continuity for legacy users.
The company's go-to-market is primarily physical and B2C: patients visit laboratory locations for sample collection and retrieve results online. There is no disclosed enterprise or B2B channel, no publicly available pricing, and no direct patient-billing model. The 51–100 employee range and the Inovie network integration indicate an operationally mature but regionally focused business that has invested selectively in digital patient experience rather than scaling new clinical capabilities.
The Bioclinic Group firmographics
Firmographics- Name
- The Bioclinic Group
- Website
- https://bioclinic.fr
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Bioclinic Group is a French medical biology laboratory operator founded in 1995, running a network of patient-facing labs across eight Île-de-France departments and serving individual patients through the INOVIE +ME digital platform and Resulabo secure results portal.
- Ownership category
- akta.pro rank
The Bioclinic Group industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
Keywords
Where The Bioclinic Group is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Markets served
The Bioclinic Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D
Distribution channels1 record
The Bioclinic Group product offering
Product offeringCore offering
The Bioclinic Group operates a network of medical biology laboratories across the Paris region (departments 75, 77, 78, 91, 92, 93, 94, 95), delivering clinical diagnostic services including blood tests and analyses. The company complements in-lab testing with secure online access to results via the Resulabo portal and a virtual chatbot assistant for personalized patient support, with laboratories now integrated under the Inovie +ME platform.
Product overview
The Bioclinic Group operates a network of medical biology laboratories in the Paris region (departments 75, 77, 78, 91, 92, 93, 94, 95). Their product portfolio centers on INOVIE +ME, a unified patient-facing digital platform that consolidates access to laboratory services. This core platform integrates a secure test results portal (Resulabo), a virtual assistant chatbot for personalized patient support, FAQ resources, and laboratory information and news. The portfolio follows a platform-plus-features architecture, with INOVIE +ME serving as the central hub for patient interactions across multiple department-specific laboratory locations.
Differentiator
Problem solved
Functional benefit
Products and services
- INOVIE +ME A modern patient-facing web platform providing tools to simplify healthcare journeys in Bioclinic laboratories. It includes secure test result access, FAQ resources, laboratory information, news, and a virtual assistant chatbot, serving individual patients across the Paris region.
- Resulabo Secure Results Portal Secure online server for accessing medical biology laboratory test results, organized by department-specific portals (Bioclinic for departments 78-92-95, Guevalt for departments 75-93-94, Sommeville for departments 77-91). Targets individual patients who have undergone laboratory testing.
Companies that use The Bioclinic Group
Customer profileSegments1 record
Ideal customer profiles1 record
The Bioclinic Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
The Bioclinic Group partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
The Bioclinic Group competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key risks2 records
Key highlights6 records
Customer concentration
The Bioclinic Group social profiles
Digital presenceThe Bioclinic Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Bioclinic Group leadership team
Management profileNumber of profiles
Profiles1 record
The Bioclinic Group funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Bioclinic Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Bioclinic Group
What does The Bioclinic Group do?
The Bioclinic Group operates a network of medical biology laboratories across the Paris region (departments 75, 77, 78, 91, 92, 93, 94, 95), delivering clinical diagnostic services including blood tests and analyses. The company complements in-lab testing with secure online access to results via the Resulabo portal and a virtual chatbot assistant for personalized patient support, with laboratories now integrated under the Inovie +ME platform.
When was The Bioclinic Group founded?
The Bioclinic Group was founded in 1995. It employs 51 to 100 people.
Where is The Bioclinic Group based?
The Bioclinic Group is headquartered in Paris, France, in the Europe region.
Does The Bioclinic Group have an API?
No public API is recorded for The Bioclinic Group.
What industry is The Bioclinic Group in?
The Bioclinic Group's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 621511 and its SIC code is 8071.